[go: up one dir, main page]

MX2018004322A - Metodo para detectar anticuerpos neutralizantes contra la insulina mana recombinante en suero mano. - Google Patents

Metodo para detectar anticuerpos neutralizantes contra la insulina mana recombinante en suero mano.

Info

Publication number
MX2018004322A
MX2018004322A MX2018004322A MX2018004322A MX2018004322A MX 2018004322 A MX2018004322 A MX 2018004322A MX 2018004322 A MX2018004322 A MX 2018004322A MX 2018004322 A MX2018004322 A MX 2018004322A MX 2018004322 A MX2018004322 A MX 2018004322A
Authority
MX
Mexico
Prior art keywords
hand
neutralizing antibodies
serum
antibodies against
against insulin
Prior art date
Application number
MX2018004322A
Other languages
English (en)
Other versions
MX384636B (es
Inventor
Kulshrestha Abhishek
Shankar Maurya Ravi
Sabde Sudeep
Hajela Pallavi
Kalani Pawan
Melarkode Ramakrishnan
Chirmule Narendra
Original Assignee
Biocon Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocon Ltd filed Critical Biocon Ltd
Publication of MX2018004322A publication Critical patent/MX2018004322A/es
Publication of MX384636B publication Critical patent/MX384636B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/62—Insulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención proporciona un método in vitro para detectar la presencia de anticuerpos neutralizantes contra insulina humana recombinante (rHI) en suero humano. También proporciona un kit para un método in vitro para la detección de la presencia de anticuerpos neutralizantes para insulina humana recombinante (rHI).
MX2018004322A 2015-10-15 2016-10-15 Método para detectar anticuerpos neutralizantes contra la insulina humana recombinante en suero humano. MX384636B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN5528CH2015 2015-10-15
PCT/IB2016/056191 WO2017064678A1 (en) 2015-10-15 2016-10-15 Method for detecting neutralizing antibodies against recombinant human insulin in human serum

Publications (2)

Publication Number Publication Date
MX2018004322A true MX2018004322A (es) 2018-11-09
MX384636B MX384636B (es) 2025-03-14

Family

ID=58518001

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018004322A MX384636B (es) 2015-10-15 2016-10-15 Método para detectar anticuerpos neutralizantes contra la insulina humana recombinante en suero humano.

Country Status (9)

Country Link
US (1) US11340238B2 (es)
EP (1) EP3362793B1 (es)
JP (1) JP6835835B2 (es)
AU (1) AU2016337598B2 (es)
CA (1) CA3000929C (es)
MX (1) MX384636B (es)
MY (1) MY192159A (es)
RU (1) RU2725142C2 (es)
WO (1) WO2017064678A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210284716A1 (en) 2020-03-11 2021-09-16 Immunitybio, Inc. ACE2-Fc Trap
US11857620B2 (en) 2020-03-11 2024-01-02 Immunitybio, Inc. Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus
US12285480B2 (en) 2020-03-11 2025-04-29 Nantcell, Inc. Method of inducing immunity against SARS-CoV-2 using spike and nucleocapsid-ETSD immunogens delivered by RNA and replication-defective adenoviruses
CN112362649B (zh) * 2020-11-09 2024-07-12 长春金赛药业有限责任公司 一种rhGH中和抗体的检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225583A (en) * 1987-08-06 1991-07-26 Merck & Co Inc Process for purifying hepatitis a virions (hav)
WO1995023231A1 (en) 1994-02-28 1995-08-31 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Cell lines for the identification of substances affecting insulin receptor mediated signal transduction
US7087726B2 (en) * 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
JP4197180B2 (ja) * 2005-06-29 2008-12-17 株式会社シバヤギ 検体中の内分泌物質測定方法
CA2694034A1 (en) * 2007-07-27 2009-02-05 Pfizer Limited Antibody purification process by precipitation
CA2885721A1 (en) 2012-07-11 2014-01-16 Biomimetic Therapeutics, Llc Cell-based assay for neutralizing antibodies
LT3105592T (lt) * 2014-02-11 2019-01-25 Genzyme Corporation Antikūnų prieš vaistus buvimo arba jų kiekio aptikimo analizė

Also Published As

Publication number Publication date
CA3000929A1 (en) 2017-04-20
JP6835835B2 (ja) 2021-02-24
MY192159A (en) 2022-08-03
JP2018532115A (ja) 2018-11-01
RU2725142C2 (ru) 2020-06-30
US11340238B2 (en) 2022-05-24
RU2018114524A (ru) 2019-11-15
US20180306814A1 (en) 2018-10-25
WO2017064678A1 (en) 2017-04-20
AU2016337598A1 (en) 2018-04-26
RU2018114524A3 (es) 2020-02-26
CA3000929C (en) 2023-09-19
MX384636B (es) 2025-03-14
AU2016337598B2 (en) 2022-10-13
EP3362793A1 (en) 2018-08-22
BR112018007551A2 (pt) 2018-10-23
EP3362793A4 (en) 2018-08-22
EP3362793B1 (en) 2019-08-28

Similar Documents

Publication Publication Date Title
BR112016027475A2 (pt) kit, dispositivo e método para a detecção de câncer pancreático
BR112016029583A2 (pt) ?kit ou dispositivo para a detecção de câncer esofágico e método de detecção?
CU20160101A7 (es) Inmunoglobulina con fab en tándem
EP3967769A3 (en) Lung cancer detection kit or device, and detection method
AR090973A1 (es) Anticuerpos utiles para el diagnostico del cancer
GB201305223D0 (en) Reflection detection type measurement apparatus for skin autofluorescence
GT201300233A (es) Receptores de celulas t similares a anticuerpos especificos para un peptido wt1 presentado por hla-a2
CR20170282A (es) Nuevos péptidos y nueva combinación de péptidos para el uso en la inmunoterapia contra el carcinoma hepatocelular (chc) y otros tipos de cáncer
EA201592269A1 (ru) Способы и композиции для снижения иммуносупрессии опухолевыми клетками
EP3862439A3 (en) Liver cancer detection kit or device, and detection method
IN2014DN04645A (es)
BR112016028944A2 (pt) kit ou dispositivo para a detecção de câncer do trato biliar e método de detecção
MX374652B (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco.
EP3971299A3 (en) Colorectal cancer detection kit or device, and detection method
CR20160199A (es) Terapia combinada con un anticuerpo anti-ang2 y un agonista de cd40
EP3800253A3 (en) Prostate cancer detection kit or device, and detection method
PL3138489T3 (pl) Zestaw do określania stężenia analitu
MX2021006791A (es) Metodos y composiciones para detectar proteinas mal plegadas.
EP3134105B8 (en) Peptide analogues with branched amino acid probe(s)
MX2019001026A (es) Anticuerpos de antihemaglutinina y metodos de uso.
MX2018004322A (es) Metodo para detectar anticuerpos neutralizantes contra la insulina mana recombinante en suero mano.
MX2019002818A (es) Metodos para detectar anticuerpos neutralizantes anti-leptina.
BR112017023473A2 (pt) método de detecção e quantificação de ácido nucleico e composições
WO2015077342A3 (en) Detection of arginine methylation of egfr for prediction of resistance to therapy
EP3004375A4 (en) Protease-responsive peptide biosensors and methods for analyte detection